Alterations in phencyclidine and sigma binding sites in schizophrenic brains: Effects of disease process and neuroleptic medication
- 31 December 1991
- journal article
- Published by Elsevier in Schizophrenia Research
- Vol. 6 (1) , 41-48
- https://doi.org/10.1016/0920-9964(91)90019-n
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Schizophrenia: the cellular biology of a functional psychosisTrends in Neurosciences, 1990
- (3H]MK-801 binding sites in postmortem brain regions of schizophrenic patientsJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1989
- Frontal Cortical and Left Temporal Glutamatergic Dysfunction in SchizophreniaJournal of Neurochemistry, 1989
- Divergent ontogeny of sigma and phencyclidine binding sites in the rat brainDevelopmental Brain Research, 1989
- Neurotransmitters, receptors and neuropeptides in post‐mortem brains of chronic schizophrenic patientsActa Psychiatrica Scandinavica, 1988
- HR 375: A potential antipsychotic drug that interacts with dopamine D2 receptors and σ-receptors in the brainNeuroscience Letters, 1986
- Evidence that the potential antipsychotic agent rimcazole (BW 234U) is a specific, competitive antagonist of sigma sites in brainLife Sciences, 1986
- A study of the septum pellucidum and corpus callosum in schizophrenia with MR imagingActa Psychiatrica Scandinavica, 1985
- Phencyclidine (PCP): A Review and PerspectivesCRC Critical Reviews in Toxicology, 1982
- One Degree of Freedom for Non-AdditivityPublished by JSTOR ,1949